Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
METATEL: Telmisartan in Metabolic Syndrome
NCT00560430Phase 3Completed
- Sponsor
- Ludwig Maximilian University of Munich
- Start
- Nov 2007
- Primary completion
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of telmisartan in hypertension (HTN), metabolic syndrome, sponsored by Ludwig Maximilian University of Munich. Started Nov 2007; status: completed.
02
Drugs
telmisartan
03
Conditions
hypertension (HTN)metabolic syndrome
Beyond the preview
Go deeper on NCT00560430.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00560430.